2U3:FRA
Alcon AG
€57.08
arrow_upward
+1.17%(+0.66) 1D
Sep 30, 8:15:02 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2U3...
Open
€57.08
High
€57.08
Low
€57.08
Mkt. cap
27.21B
Avg. vol.
237.00
Volume
0.00
52-wk high
€73.96
52-wk low
€51.78
No. of employees
25K
Open
€57.08
High
€57.08
Low
€57.08
Mkt. cap
27.21B
Avg. vol.
237.00
Volume
0.00
52-wk high
€73.96
52-wk low
€51.78
No. of employees
25K
News stories
From web sources and news partners
AD HOC NEWS
·
2 hours ago
Alcon stock launches Systane PRO PF in Canada
Simply Wall St
·
13 hours ago
Did Dry Eye Drop Launch Just Shift Alcon's (SWX:ALC) Investment Narrative?
TipRanks
·
18 hours ago
Lifecore Biomedical Extends Key Manufacturing Pact with Alcon
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Websitealcon.com